State Attorneys General Lobby the U.S. to Lower the Cost of Coronavirus Drug Remdesivir
A group of 31 state attorneys general have submitted a formal letter urging the federal government to use its powers to reduce the cost and increase the supply of Gilead Sciences' (NASDAQ: GILD) coronavirus drug remdesivir.
The bipartisan group of attorneys general is concerned that the price Gilead has set for remdesivir -- $3,120 for most U.S. patients, or $520 per vial -- is prohibitive. They also believe the manufacture of the drug should be licensed to third parties.
Image source: Getty Images.
Source Fool.com
